Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

No Inauguration For Chavez; These ETFs May be in Play

After the close of U.S. markets Tuesday, Bloomberg reported Venezuelan President Hugo Chavez will not be sworn in on Thursday January 10. The likely reason is his ailing health. Chavez has been in Cuba for several weeks recovering from a fourth procedure to treat cancer.

Last week, it was reported that Chavez’s situation was delicate. One leading physician even said the Venezuelan leader was leading his last days.

Until this week, concerns over the Venezuelan succession plan have not been a hindrance to the country’s bonds or the small amount of U.S.-listed ETFs that offer exposure to Venezuelan debt, the only way for most American investors to access the South American OPEC member.

However, on Monday, bonds issued by Petroleos de Venezuela, the country’s state-run oil producer, sank on succession fears. PDVSA’s debt due 2017 plunged 1.88 cents to 99.09 cents on the dollar yesterday, Bloomberg reported.

That bond issue is featured in the Market Vectors ETF Trust (NYSEARCA:HYEM), an ETF that features an 8.73 percent weight to Venezuela. Another Petroleos De Venezuela issue, this one maturing in 2014 with a 4.9 percent coupon, is also found among HYEM’s top-10 lineup. The ETF eked a positive finish on Tuesday on light volume.

To this point, market participants have seemed resigned to the fact that if Chavez could not be sworn in on January 10, Vice President Nicolas Maduro would assume the presidency. Worth noting is that Venezuela’s constitution mandates that new elections must be held within 30 days if Chavez is not sworn in on January 10.

iShares Dow Jones US Home Const. (ETF) (NYSEARCA:ITB)

It could be the specter of Maduro, who Chavez has told Venezuelans to vote for if something should happen to him, taking over that has roiled Venezuelan bonds. The iShares Emerging Markets High Yield Bond Fund (BATS:EMHY), which now features an allocation of almost 17.5 percent to Venezuela, touched a new all-time high early Monday, but sold-off throughout the day and closed lower on Tuesday.

Over the past five trading days, the Market Vectors ETF Trust (NYSEARCA:BONO), the the only other ETF with noticeable direct Venezuela exposure, is lower by about one percent.

The recent decline in Venezuelan bonds could pressure these ETFs, but the upside is a buying opportunity could emerge on hopes Venezuelans will see Chavez not taking office again as an opportunity to elect a pro-free market regime.

Venezuela needs to do that because the company’s status as an OPEC member belies faltering production and the fact that Petroleos de Venezuela is by many accounts a decrepit company. In 2011, the country had the second-largest oil reserves in the world and reserves could be as high as 316 billion barrels when factoring in the Orinoco Belt, according to the Energy Information Administration.

Problem is Venezuela’s oil is nationalized and Chavez did more to scare Western oil companies operating there than to welcome their much-needed investments and technology.

Should Venezuela make the transition from leftist regime to some semblance of a free market country, then another ETF becomes an interesting way to profit from that trend: The iShares S&P Global Energy Sector (NYSEARCA:IXC).

At least five of IXC’s top-10 holdings – Exxon Mobil Corporation (NYSE:XOM), Chevron Corporation (NYSE:CVX), ConocoPhillips (NYSE:COP), BP plc (NYSE:BP) and Eni SpA (NYSE:E) – have some exposure to Venezuela. That implies a new, non-leftist regime there could be a boon for more than just bonds. It could be good news for some of the most familiar oil stocks as well.

This article was originally written by The ETF Professor, and posted on Benzinga.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!